Great West Life Assurance CO Karuna Therapeutics, Inc. Transaction History

Great West Life Assurance CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$161.01 - $317.85 $57,158 - $112,836	355 Added 13.45%	2,994 $941,000
Q3 2023 Nov 14, 2023	BUY	$164.66 - $218.08 $230,524 - $305,312	1,400 Added 112.99%	2,639 $446,000
Q2 2023 Aug 10, 2023	SELL	$176.32 - $240.22 $11,460 - $15,614	-65 Reduced 4.98%	1,239 $270,000
Q1 2023 May 12, 2023	SELL	$161.33 - $204.36 $18,230 - $23,092	-113 Reduced 7.97%	1,304 $237,000
Q3 2022 Nov 01, 2022	BUY	$123.79 - $277.42 $175,410 - $393,104	1,417 New	1,417 $318,000
Q2 2021 Aug 11, 2021	BUY	$107.45 - $135.95 $16,762 - $21,208	156 Added 17.51%	1,047 $119,000
Q2 2020 Aug 17, 2020	BUY	$62.14 - $117.21 $55,366 - $104,434	891 New	891 $99,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.